Summary
Symptomatic cerebral vasospasm (CVS) with delayed ischemic neurologic deficits affects about one third of the patients after aneurysmal subarachnoid hemorrhage (SAH). In spite of the lack of definite evidence of large clinical trials, the devastating outcome of the natural history of symptomatic CVS demands an aggressive CVS treatment in a practically oriented, structured multimodal treatment regimen. With our treatment protocol good functional outcome could be reached in 66% of the patients with symptomatic CVS. This policy requires close and fast multidisciplinary collaboration between neurosurgeons, neuroradiologists, competent in endovascular interventions, and specialists for neurointensive care. We report on our experience with 79 cases with symptomatic CVS and delayed ischemic neurologic deficit (DIND) after aneurysmal SAH. The different treatment options with CVS are reviewed and practical guidelines for a step by step treatment are given.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Aaslid R, Huber P, Nornes H (1984) Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 60: 37–41
Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR (1983) Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308: 619–624
Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M (2002) Indications for endovascular treatment therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage. Experience at the University of Cincinnati. Surg Neurol 58: 131–138
Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S (2001) Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery 48: 723–730
Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr (1987) Clinical vasospasm after subarachnoid hemorrhage: Cerebral vasospasm: results of a structured multimodal treatment 71 response to hypervolemic hemodilution and arterial hypertension. Stroke 18: 365–372
Barker FG, Ogilvie CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84: 405–414
Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346: 557–563
Biggar WD, Bohn D, Kent G (1983) Neutrophil circulation and release from bone marrow during hypothermia. Infect Immun 40: 708–712
Blaustein MP, Ector AC (1975) Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro. Mol Pharmacol 11: 369–378
Boet R, Mee E (2000) Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 47: 602–607
Busto R, Dietrich WD, Globus MY, Ginsberg MD (1989) Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett 101: 299–304
Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES, Mayer SA (2001) Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage. The Fisher scale revisted. Stroke 32: 2012–2020
Dalen JE, Bone RC (1996) Is it time to pull the pulmonary artery catheter? JAMA 276: 916–918
Dorsch NW (2002) Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Review. Curr Opin Crit Care 8: 128–133
Dorsch NW, Kassell NF, Sinkula MS (2001) Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH. Acta Neurochir (Wien) [Suppl] 77: 233–235
Dorsch NW (1994) A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part II: management. J Clin Neurosci 1: 78–92
Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y (1998) Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 89: 93–100
Finfer SR, Ferch R, Morgan MK (1999) Barbiturate coma for severe, refractory vasospasm following subarachnoid haemorrhage. Intensive Care Med 25: 406–409
Gasser S, Khan N, Yonekawa Y, Imhof HG, Keller E (2003) Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage: feasibility and intensive care complications. J Neurosurg Anesthesiol 15: 240–248
Hegner T, Krayenbuhl N, Hefti M, Yonekawa Y, Keller E (2001) Bedside monitoring of cerebral blood flow in patients with subarachnoid hemorrhage. Acta Neurochir (Wien) [Suppl] 77: 131–134
Hindman BJ, Todd MM, Gelb AW, Loftus CM, Craen RA, Schubert A, Mahla ME, Torner JC (1999) Mild hypothermia as a protective therapy during intracranial aneurysm surgery: a randomized prospective pilot trial. Neurosurgery 44: 23–33
Hoeft A, Schorn B, Weyland A, Scholz M, Buhre W, Stepanek E, Allen SJ, Sonntag H (1994) Bedside assessment of intravascular volume status in patients undergoing coronary bypass surgery. Anesthesiology 81: 76–86
Janjua N, Mayer SA (2003) Cerebral vasospasm after subarachnoid hemorrhage. Review. Curr Opin in Crit Care 9: 113–119
Jennett B, Snoek J, Bond MR, Brooks N (1981) Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 44: 285–293
Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K (1992) Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77: 842–848
Karibe H, Sato K, Shimizu H, Tominaga T, Koshu K, Yoshimoto T (2000) Intraoperative mild hypothermia ameliorates postoperative cerebral blood flow impairment in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 47: 594–601
Kassell NF, Peerless SJ, Drake CG, Boarini DJ, Adams HP (1980) Treatment of ischemic deficits from cerebral vasospasm with high dose barbiturate therapy. Neurosurgery 7: 593–597
Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84: 221–228
Kassell NF, Peerless SJ, Durward QJ, Beck Dw, Drake CG, Adams HP (1982) Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11: 337–343
Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams Hp, Kongable GL (1990) The international cooperative study on timing of aneursym surgery. Part 1: overall management results. J Neurosurg 73: 18–36
Keller E, Imhof HG, Gasser S, Terzic A, Yonekawa Y (2003) Endovascular cooling with heat exchange cateheters: A new method to induce and maintain hypothermia. Intensive Care Med 29: 939–943
Keller E, Nadler A, Alkhadi H, Kollias SS, Yonekawa Y, Niederer P (2003) Non invasive measurement of regional cerebral blood flow and regional cerebral blood volume by near infrared spectroscopy and indocyanaine green dye dilution. Neuroimage 20: 828–839
Keller E, Steiner T, Fandino J, Schwab S, Hacke W (2002) Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients: lessons from a preliminary study. J Neurosurg Anesthesiol 14: 130–136
Keller E, Wietasch G, Ringleb P, Scholz M, Schwarz S, Stingele R, Schwab S, Hanley D, Hacke W (2000) Bedside monitoring of cerebral blood flow in patients with acute hemispheric stroke. Crit Care Med 28: 511–516
Keller E, Wolf M, Martin M, Yonekawa Y (2001) Estimation of cerebral oxygenation and hemodynamics in cerebral vasospasm using indocyaningreen dye dilution and near infrared spectroscopy: a case report. J Neurosurg Anesthesiol 13: 43–48
Krayenbühl NT, Hegner T, Yonekawa Y, Keller E (2000) Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new of systemic hemodynamics parameters. Acta Neurochir (Wien) [Suppl] 77: 247–250
Lennihan L, Mayer S, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA (2000) Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31: 383–391
Lindegaard KF (1999) The role of transcranial Doppler in the management of patients with subarachnoid hemorrhage: a review. Acta Neurochir (Wien) [Suppl] 72: 59–71
Maher J, Hachinski V (1993) Hypothermia as a potential treatment for cerebral ischemia. Review. Cerebrovasc Brain Metab Rev 5: 277–300
Manno EM, Gress DR, Schwamm LH, Diringer MN, Ogilvy CS (1998) Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke 29: 422–428
McFadden JP (1988) Hypothermia-induced thrombocytopenia. J R Soc Med 81: 677
Meyer FB (1990) Calcium antagonists and vasospasm. Review. Neurosurg Clin N Am 1: 367–376
Mori T, Katayama Y, Kawamata T, Hirayama T (1999) Improved efficiency of hypervolemic therapy with inhibition of natruiresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 91: 947–952
Nagao S, Irie K, Kawai N, Kunishio K, Ogawa T, Nakamura T, Okauchi M (2000) Protective effect of mild hypothermia on symptomatic vasospasm: a preliminary report. Acta Neurochir (Wien) [Suppl] 76: 547–550
Nagao S, Irie K, Kawai N, Nakamura T, Kunishiro K, Matsumoto Y (2003) The use of mild hypothermia for patients with severe vasospasm: a preliminary report. J Clin Neurosci 10: 208–212
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298: 36–42
Piepgras A, Elste V, Frietsch T, Schmiedek P, Reith W, Schilling L (2001) Effiect of moderate hypothermia on experimental severe subarachnoid hemorrhage, as evaluated by apparent diffusion coefficient changes. Neurosurgery 48: 1128–1135
Pina-Cabral JM, Ribeiro-da-Silva A, Almeida-Dias A (1985) Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine — reversibility accelereated after intra-abdominal rewarming. Thromb Haemost 54: 838–841
Pluta RM, Thompson BG, Afshar JK, Boock RJ, Juliano B, Oldfield EH (2001) Nitric oxide and vasospasm. Acta Neurochir (Wien) [Suppl] 77: 67–72
Raper R, Sibbald WJ (1986) Misled by the wedge? The Swan-Ganz catheter and left ventricular preload. Chest 89: 427–434
Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH (1983) Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 12: 658–661
Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N (2003) Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Review. Lancet Neurol 2: 614–621
Shapiro HM, Galindo A, Wyte SR, Harris AB (1973) Rapid intraoperative reduction of intracranial pressure with thiopentone. Br J Anaesth 45: 1057–1062
Shenaq SA, Yawn DH, Saleem A, Joswiak R, Crawford ES (1986) Effect of profound hypothermia on leukcytes and platelets. Ann Clin Lab Sci 16: 130–133
Shibuya M, Asano T, Sasaki Y (2001) Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Acta Neurochir (Wien) [Suppl] 77: 201–204
Smith SL, Hall ED (1996) Mild pre-and posttraumatic hypothermia attenuates blood-brain barrier damage following controlled cortical impact injury in the rat. J Neurotrauma 13: 1–9
Solenski NJ, Haley EC JR, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC (1995) Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter study, Participants of the multicenter cooperative aneurysm study. Crit Care Med 23: 1007–1017
Stover JF, Stocker R (1998) Barbiturate coma may promote reversible bone marrow suppression in patients iwth severe isolated traumatic brain injury. Eur J Clin Pharmacol 54: 529–534
Valeri CR, Feingold H, Cassidy G, Ragno G, Khuri S, Altschule MD (1986) Hypothermia-induced reversible platelet dysfunction. Ann Surg 205: 175–181
Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM (2002) Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96: 510–514
Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM (1999) Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44: 1237–1248
Waller MB, Richter JA (1980) Effects of pentobarbital and Ca2+ on the resting and K+-stimulated release of several endogenous neurotransmitters from rat midbrain slices. Biochem Pharmacol 29: 2189–2198
Wijdicks EF, Ropper AH, Hunnicutt EJ, Richardson GS, Nathanson JA (1991) Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 22: 1519–1524
Yasargil MG (1984) Clinical Considerations. Surgery of the intracranial aneurysms and results, vol II. Thieme, New York Stuttgart, pp 1–32
Zuccarello M (2001) Endothelin: the “prime suspect” in cerebral vasospasm. Review. Acta Neurochir (Wien) [Suppl] 77: 61–65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag
About this paper
Cite this paper
Keller, E., Krayenbühl, N., Bjeljac, M., Yonekawa, Y. (2005). Cerebral vasospasm: results of a structured multimodal treatment. In: Yonekawa, Y., Keller, E., Sakurai, Y., Tsukahara, T. (eds) New Trends of Surgery for Stroke and its Perioperative Management. Acta Neurochirurgica Supplements, vol 94. Springer, Vienna. https://doi.org/10.1007/3-211-27911-3_11
Download citation
DOI: https://doi.org/10.1007/3-211-27911-3_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-24338-1
Online ISBN: 978-3-211-27911-3
eBook Packages: MedicineMedicine (R0)